Latham Guides Genstar In $400M Pharma Research Co. Buy

Law360, New York (April 10, 2012, 2:28 PM ET) -- San Francisco-based private equity firm Genstar Capital LLC plans to buy up eResearchTechnology Inc., a research service provider for bio-pharmaceutical companies, for about $400 million, the Philadelphia-based data cruncher said Tuesday.

Having inked a definitive agreement and gotten support from the company's board of directors, Genstar plans to purchase the global research firm for $8 per share in an all-cash deal, according to ERT. The purchase price represents a premium of about 38 percent over the company's average closing price for the last three months and...
To view the full article, register now.